Nyxoah (NYXH) EBITDA Margin (2025 - 2026)
Nyxoah's quarterly EBITDA Margin came in at 57.47% in Q1 2026, down 638.0% year-on-year from 10.68% in Q1 2025, and down 9.99% quarter-over-quarter from 63.85% in Q1 2025.
Nyxoah has reported EBITDA Margin for 2 years, with the latest figure at 57.47% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 28.86% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 19.85% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 17.48% |
| 10 | Nyxoah | 1,248.49 | 1,248.49 | 4.26 Mn | 57.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.47% |
| Mar 31, 2025 | 63.85% |